[33] Govindarajan M, Khater HF, Panneerselvam C, Benelli G. One‐pot fabrication of silver
nanocrystals using Nicandra physalodes: A novel route for mosquito vector control with
moderate toxicity on non‐target water bugs. Research in Veterinary Science. 2016; 107 :95‐
- doi:10.1016/j.rvsc.2016.05.017
[34] Rieckmann KH, Carson PE, Beaudoin RL, Cassells JS, Sell KW. Letter: Sporozoite induced
immunity in man against an Ethiopian strain of Plasmodium falciparum. Transactions of
the Royal Society of Tropical Medicine and Hygiene. 1974; 68 (3):258‐259. doi:10.1016/00
35‐9203(74)90129‐1
[35] Rieckmann KH, Beaudoin RL, Cassells JS, Sell KW. Use of attenuated sporozoites in
the immunization of human volunteers against falciparum malaria. The Bulletin of the
World Health Organization. 1979; 57 (Suppl 1):261‐265.
[36] Rts, S. Clinical trials partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine
with or without a booster dose in infants and children in Africa: final results of a phase
3, individually randomised, controlled trial. Lancet. 2015; 386 (9988):31‐45. doi:10.1016/
S0140‐6736(15)60721‐8
[37] Tran TM, Portugal S, Draper SJ, Crompton PD. Malaria vaccines: moving forward after
encouraging first steps. Current Tropical Medicine Reports. 2015; 2 (1):1‐3. doi:10.1007/
s40475‐015‐0041‐3
[38] Bloland PB. Drug Resistance in Malaria. Geneva: World Health Organization; 2001. 32 p.
[39] Noedl H. Combination Therapy in Light of Emerging Artemisinin Resistance. In:
Staines HM, Krishna S, editors. Teatment and Prevention of Malaria: Antimalarial
Drug Chemistry, Action and Use. 1st ed. Springer, Basel; 2012. pp. 213‐225.
doi:10.1007/978‐3‐0346‐0480‐2
[40] Aurrecoechea C, Brestelli J, Brunk BP, Dommer J, Fischer S, Gajria B, et al. PlasmoDB: a
functional genomic database for malaria parasites. Nucleic Acids Research. 2009; 37 (Suppl
1):D539‐D543. doi:10.1093/nar/gkn814
[41] Dame JB, Yowell CA, Omara‐Opyene L, Carlton JM, Cooper RA, Li T. Plasmepsin 4, the
food vacuole aspartic proteinase found in all Plasmodium spp. infecting man. Molecular
and Biochemical Parasitology. 2003; 130 (1):1‐12. doi:10.1016/s0166‐6851(03)00137‐3
[42] Coombs GH, Goldberg DE, Klemba M, Berry C, Kay J, Mottram JC. Aspartic prote‐
ases of Plasmodium falciparum and other parasitic protozoa as drug targets. Trends in
Parasitology. 2001; 17 (11):532‐537. doi:10.1016/s1471‐4922(01)02037‐2
[43] Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool.
Journal of Molecular Biology. 1990; 215 (3):403‐410. doi:10.1016/S0022‐2836(05)80360‐2
[44] Silvestrini F, Lasonder E, Olivieri A, Camarda G, van Schaijk B, Sanchez M, et al..
Protein export marks the early phase of gametocytogenesis of the human malaria
parasite Plasmodium falciparum. Molecular & Cellular Proteomics. 2010; 9 (7):1437‐1448.
doi:10.1074/mcp.M900479‐MCP200
Plasmepsin: Function, Characterization and Targeted Antimalarial 'rug 'evelopment
http://dx.doi.org/10.5772/66716207